IRIS Registry National Clinical Registry for Eye Disease Care and Quality Improvement

What this Trial Is About

The IRIS Registry Intelligent Research in Sight is the first national eye disease clinical registry in the United States, developed by the American Academy of Ophthalmology. It is designed as a clinical self-improvement tool to help ophthalmologists compare patient outcomes, professional performance, and care processes nationwide. The registry aims to support continuous quality enhancement in eye care practices across the country. This registry collects and analyzes data from ophthalmic ambulatory encounters to promote practice innovations and improve patient care. It allows doctors to monitor patient interactions, track interventions, identify quality gaps, and manage clinical conditions for entire patient populations. Practices can benchmark their results against national data and use the information to optimize care and resource use. Participants contribute data over time, enabling ongoing evaluation of various eye conditions such as glaucoma, macular degeneration, diabetic retinopathy, cataracts, melanoma, and others. The registry measures outcomes like eye exam results, treatment success, patient satisfaction, and preventive care over periods up to five years. This long-term data collection supports continuous quality improvement and benchmarking among ophthalmology practices.

IRIS Registry: Intelligent Research in Sight Registry